Re: Thoughts on ZCC
in response to
by
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: Re: Thoughts on ZCC
Does it make sense for Zenith Capital Corp., to go totally private? This way it will lose its ZHCLF OTC $0.25-$0.30 US sting.
Don should have gone with an IPO years ago.
Koo
3 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply